CT:IQ is delighted to announce the addition of Contract Research Organisation (CRO) Fortrea to our Steering Committee. Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. Fortrea partners with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing […]
News
Register for our eNews
ObvioHealth joins CT:IQ Steering Committee
CT:IQ is thrilled to announce our newest Steering Committee member, ObvioHealth. ObvioHealth, a virtual research organisation (VRO), brings a wealth of experience and expertise in conducting decentralised clinical trials (DCTs) that produce stronger therapeutic evidence. Its mission is to conduct innovative and efficient trials using technology to capture more robust and accurate data—so life-improving innovations […]
CSIRO joins CT:IQ’s Steering Committee
We are thrilled to announce CT:IQ’s newest Steering Committee member: CSIRO. As Australia’s national science agency, CSIRO’s purpose is to solve Australia’s greatest challenges through innovative science and technology. CSIRO works with industry, government and the research community to turn science into solutions, addressing issues including food security and quality; sustainable energy and resources; health […]
CT:IQ Welcomes Ramsay Health Care
We are pleased to welcome CT:IQ’s newest member, Ramsay Health Care. Founded in 1964, Ramsay is now one of the largest and most diverse private healthcare companies in the world, employing more than 88,000 people and treating millions of people every year. Ramsay offers quality healthcare through hundreds of facilities and community services in Australia, […]
Welcome MinterEllison to CT:IQ Steering Committee
We are delighted to welcome a new member to CT:IQ’s Steering Committee, MinterEllison. MinterEllison is one of Australia’s largest law firms, with nearly 200 years of business history. MinterEllison partners with clients to provide integrated, innovative solutions. Its teams collaborate across Australia, Asia and the UK to deliver exceptional service and new insight to a […]
CT:IQ welcomes Roche to Steering Committee
We are delighted to welcome a new member to CT:IQ’s Steering Committee, Roche. Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics, as well as growing capabilities in the area of data-driven medical insights help Roche deliver truly personalised healthcare. […]
AccessCR joins CT:IQ Steering Committee
We are pleased to announce AccessCR has joined CT:IQ’s Steering Committee. AccessCR is a social enterprise providing services to the research sector to engage with and involve health consumers in research and development with a view to helping improve the relevance, efficiency of, and participant experience in, clinical trials that lead to advancements in health […]
Get the D.I.R.T. on Digitalisation of Clinical Trials Summit & Dinner
On 23 November, CT:IQ will be partnering with ARCS Australia on the Summit Get the D.I.R.T. on digitalisation of clinical trials. The Summit will provide a forum for discussing the potential benefits and challenges of digitalisation, and to agree on priorities to ensure Australia leverages digital technologies to progress effective and inclusive medical research. Who should attend? […]
Consentic joins CT:IQ Steering Committee
We are delighted to announce that Consentic has joined CT:IQ’s Steering Committee. Consentic is an eConsent platform for medical, dental and clinical trial consent, providing a comprehensive library of patient-tested, medicolegally-reviewed consent animations with interactive checklists and secure electronic consent forms. Consentic optimises and streamlines consent, and is clinically proven to result in enhanced patient understanding, […]
Welcome Pharmaceutical Product Development (PPD) to CT:IQ Steering Committee
CT:IQ is delighted to welcome Pharmaceutical Product Development (PPD) to the Steering Committe. PPD, part of Thermo Fisher Scientific, is a leading global contract research organisation (CRO) focused on delivering life-changing therapies. PPD provides comprehensive lab services, integrated drug development, clinical trial therapeutic expertise and lifecycle management services. In December 2021, PPD became a wholly owned […]